결핵 진료지침
56. and meta-analysis. Eur Respir J 2017;50.
57. Cheon J, Kim C, Park EJ, Ock M, Lee H, Ahn JJ, et al. Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea. J Thorac Dis 2020;12:4950–9.
58. Korea Central Cancer Registry. National Cancer Center. Annual report of cancer statistics in Korea in 2020. Ministry of Health and Welfare; 2022. p.
59. Langan EA, Graetz V, Allerheiligen J, Zillikens D, Rupp J, Terheyden P. Immune checkpoint inhibitors and tuberculosis: an old disease in a new context. Lancet Oncol 2020;21:e55–e65.
60. Park HY, Choi SH, Kim D, Hwang J, Kwon Y, Kwon JW. Incidence and risk factors of tuberculosis in patients following gastrectomy or endoscopic submucosal dissection: a cohort analysis of country-level data. Gastric Cancer 2023;26:405–14.
61. Baussano I, Nunn P, Williams B, Pivetta E, Bugiani M, Scano F. Tuberculosis among health care workers. Emerg Infect Dis 2011;17:488–94.
62. World Health Organization. Evidence to decision framework. Appendix to the Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organisation; 2015.

Ⅷ. 잠복결핵감염 323
<PAGE>323